Objective
The AP-1 family of transcription factors participates in almost any program of gene expression, in cell proliferation, in apoptosis, in numerous types of differentiation, in cancer and autoimmune disease. Enhanced understanding of AP-1 function has significant scientific benefit and important implications for the development of inhibitory drugs and technological innovations in the healthcare industry. It is of utmost importance to dissect the molecular functions of the AP-1 factors, to study how physiologic regulators affect these functions and to then design strategies of intervention for appropriate pathologies. Due to the complexity of the AP-1 family and the need to dissect the specific role of single members of the family by mouse genetics it is mandatory to approach this theme as a collaboration of several laboratories. The participant to this research-training network together have already generated gene disruption of most of the AP-1 members and characterized their phenotypes. The availability of mouse models and highly informative in vitro systems to study specific aspects of physiological and pathological processes represent a unique tool to fully understand the role of each member of the family. Objectives of the present proposal are the dissection of AP-1 function with the aim of mouse genetics and in vitro analysis of cell mutants. First, the generation of a second generation of mutant and transgenic animals to answer to specific questions raised by the increased knowledge. Second, derive specific primary cell and cell lines lacking single AP-1 genes or expressing specific AP- I dimmers. Third, analyze in reconstituted in vitro models the role of AP-1 factors in differentiation pathways cell cycle progression or cell transformation. Fourth, identification of new AP-1 target genes by gene expression analysis performed with mutant cell clones using the micro array technology and with proteomic analysis. Fifth, functional analysis of relevant
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine immunology autoimmune diseases
- natural sciences biological sciences genetics RNA transcriptomes
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine pathology
- natural sciences mathematics pure mathematics mathematical analysis functional analysis
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Data not available
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
53100 SIENA
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.